Delivering mitochondrial health
In late October, Abliva will attend the 14th Mitochondrial Disease Conference, this year in Padua (IT), organized by the Italian patient organization Mitocon. Abliva's CMO, Magnus Hansson will give an update on the company's FALCON study with KL1333.
In early November, Abliva's CEO, Ellen Donnelly, will attend the BIO-Europe meeting in Stockholm, Sweden. Follow the link below for further details.
In mid-November, Abliva will attend LSX's Investival Showcase in London, UK. The Investival Showcase is a Biotech, Healthtech, and Medtech Networking & Pitching Event. Follow the link below for more details.
In late November, Abliva will participate in BioStock's Life Science Summit in Lund, Sweden. CMO, Magnus Hansson, will be presenting the company at 15:10 CET on November 21. For more details on the event, follow the link below.
